Date Range
toReport Types
Condition
See all (5)
Region of the Body
See all (6)
Specialties
See all (18)
Emerging Treatments
OE Recommends Topics
Multimedia
Journal
Conference Series
Evidence Series
Exercise improves long-term balance and gait in elderly women with osteopenia
Arch Intern Med. 2010 Sep 27;170(17):1548-56. doi: 10.1001/archinternmed.2010.311.
Treatment of osteopenia with melatonin effective in increasing BMD in postmenopausal women
J Pineal Res. 2015 Sep;59(2):221-9.
Evaluating raloxifene in postmenopausal Japanese women with osteoporosis or osteopenia
Clin Interv Aging. 2014 Nov 5;9:1879-1893.
Significant reduction in 6-year fragility fracture risk with zoledronate vs placebo for osteopenia
N Engl J Med. 2018 Dec 20;379(25):2407-2416. doi: 10.1056/NEJMoa1808082
Pulsing electromagnetic field treatment yields no effect on disuse osteopenia (bone loss)
Bioelectromagnetics. 2011 May;32(4):273-82. doi: 10.1002/bem.20632. Epub 2010 Dec 22
Bone loss at lumbar spine after kidney transplant reduced with IV pamidronate
Osteoporos Int. 2011 Jan;22(1):281-7
The effect of tai chi on risk factors for falls in postmenopausal women with osteopaenia
Clin Rehabil. 2010 Dec;24(12):1080-90
Substantial anti-resorptive effects achieved with 1mg and 2.5mg doses of zoledronate
J Clin Endocrinol Metab. 2012 Jan;97(1):286-92. doi: 10.1210/jc.2011-2081. Epub 2011 Nov 9
Olive leaf extract improves osteocalcin level & serum lipid profile in osteopenic women
J Nutr Health Aging. 2015;19(1):77-86
Effects of ch-OSA and Ca/Vit D3 administration in osteopenic women
BMC Musculoskelet Disord. 2008 Jun 11;9:85
Immediate effects on bone metabolism biomarkers noted with resistance training and walking
BMC Musculoskelet Disord. 2016 Jun 8;17(1):254
Antiresorptive effects of single zoledronate dose are sustained for 3 years
J Bone Miner Res. 2010 Oct;25(10):2251-5
Bone mass measurements improved with WBV therapy in AIS, osteopenic females
Osteoporos Int. 2013 May;24(5):1623-36. doi: 10.1007/s00198-012-2144-1. Epub 2012 Sep 26
Effects of 2.5mg zoledronate are long-lasting and similar to 5mg dose in osteopenic women
J Bone Miner Res. 2014 Jan;29(1):166-72. doi: 10.1002/jbmr.2009.
Positive effect of D-003 on bone mineral density in postmenopausal women
Korean J Intern Med. 2011 Jun;26(2):168-78. doi: 10.3904/kjim.2011.26.2.168. Epub 2011 Jun 1
Alendronate is an effective way of increasing BMD and reducing bone turnover
J Int Med Res. 2011;39(1):302-10
Osteoporosis Choice decision aid improves treatment experience of clinicians and patients
PLoS One. 2015 May 26;10(5):e0128063.
Combination therapy improves site-specific BMD vs. teriparatide & denosumab monotherapies
J Clin Densitom. 2016 Jul-Sep;19(3):346-51
Alendronate & zoledronate both reduce hip and vertebral fracture risk compared to placebo
Gynecol Endocrinol. 2013 Dec;29(12):1005-14. doi: 10.3109/09513590.2013.813468. Epub 2013 Sep 25
Effects of teriparatide versus risedronate following pertrochanteric fracture fixation
J Bone Joint Surg Am. 2016 Nov 16;98(22):1868-1878